|
|
|
Volumn 8, Issue 1, 2005, Pages 24-26
|
|
Editorial overview: Safety/toxicity threshold concepts in drug discovery and development
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
ATOMOXETINE;
CYTOCHROME P450 2D6;
CYTOCHROME P450 3A4;
DIETHYLNITROSAMINE;
GLYCOPROTEIN P;
IRINOTECAN;
MERCAPTOPURINE;
N (2 FLUORENYL)ACETAMIDE;
PROTEIN TYROSINE KINASE INHIBITOR;
PROTEINASE INHIBITOR;
RITONAVIR;
TAMOXIFEN;
AREA UNDER THE CURVE;
ATTENTION DEFICIT DISORDER;
BREAST CANCER;
CANCER RISK;
CARCINOGENICITY;
COLON CANCER;
DNA ADDUCT;
DOSE CALCULATION;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG EFFICACY;
DRUG FATALITY;
DRUG METABOLISM;
DRUG SAFETY;
DRUG TOLERANCE;
DRUG TOXICITY;
EDITORIAL;
FIRST PASS EFFECT;
GENETIC VARIABILITY;
GENOTOXICITY;
GENOTYPE;
HUMAN;
LONG TERM EXPOSURE;
MAXIMUM TOLERATED DOSE;
MICRODOSIMETRY;
NEUTROPENIA;
NONHUMAN;
PHARMACODYNAMICS;
PHENOTYPE;
PROTEIN TRANSPORT;
RECTUM CANCER;
RISK BENEFIT ANALYSIS;
SECOND CANCER;
SIDE EFFECT;
ANIMALS;
CARCINOGENS;
DRUG DESIGN;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
TOXICOLOGY;
|
|
EID: 12244303658
PISSN: 13676733
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|
